Publications by authors named "Stephen Castaneda"

Claim this Profile
T
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade.
Rikke B Holmgaard, David A Schaer, Yanxia Li, Stephen P Castaneda, Mary Y Murphy

J Immunother Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancer.
Yixian Zhang, Stephen Castaneda, Melissa Dumble, Maoliang Wang, Mary Mileski

Mol Cancer Ther· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models.
Francis Y F Lee, Kelly L Covello, Stephen Castaneda, Donald R Hawken, David Kan

Clin Cancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib (BMS-354825) pharmacokinetics and pharmacodynamic biomarkers in animal models predict optimal clinical exposure.
Feng R Luo, Zheng Yang, Amy Camuso, Richard Smykla, Kelly McGlinchey, Stephen Castaneda

Clin Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels.
Robert Wild, Krista Fager, Christine Flefleh, David Kan, Ivan Inigo, Stephen Castaneda

Mol Cancer Ther· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of active drug plasma concentrations achieved in cancer patients by pharmacodynamic biomarkers identified from the geo human colon carcinoma xenograft model.
Feng R Luo, Zheng Yang, Huijin Dong, Amy Camuso, Kelly McGlinchey, Stephen Castaneda

Clin Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.
Louis J Lombardo, Francis Y Lee, Ping Chen, Derek Norris, Joel C Barrish, Stephen Castaneda

J Med Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis